News

23 July 2021

Augmented Reality Project 6th SinBio Sense will transfer Synthetic Biology to Phone Screens

This week saw the launching of another innovative, ongoing project of the Vilnius-Lithuania iGEM (global synthetic biology competition) team, aiming to introduce the public to synthetic biology. Using augmented reality...

Read more

15 July 2021

VU Rector Prof. Rimvydas Petrauskas Addresses the Community: I Encourage Those Who Have Not Been Vaccinated to Do so Without…

In order to carry out studies at Vilnius University (VU) in a contact manner from September, VU Rector Prof. Rimvydas Petrauskas addressed the community, reminding him of the important mission...

Read more

14 July 2021

In Memoriam Professor Albertas Čaplinskas (1942-2021)

Professor Dr Albertas Čaplinskas, one of the founders of Informatics Science in Lithuania, laureate of the Lithuanian Science Prize, passed away on July 11, 2021. Albertas Čaplinskas was a well-known...

Read more

14 July 2021

VU’s Chemist Dr Žarkovas: Materials for Bone Regeneration Will Become Even More Relevant in the Future

Dr Aleksejus Žarkovas, researcher with the Faculty of Chemistry and Geosciences of Vilnius university (VU) and a group of fellow researchers are looking into materials for generating damaged bones and...

Read more

13 July 2021

Nord Security and Vilnius University Partner Up to Develop Innovative Solutions

Vilnius University (VU) and the cyber security solutions developer Nord Security have signed a cooperation agreement. The parties have agreed to strengthen the partnership between tertiary education and business and...

Read more

12 July 2021

Spain’s PM Pedro Sánchez and Lithuania’s PM Ingrida Šimonytė Visited Vilnius University

On 8 July, within the framework of his visit to Lithuania, Prime Minister of the Kingdom of Spain Pedro Sánchez and Prime Minister of the Republic of Lithuania Ingrida Šimonytė...

Read more

One more step towards the Nobel Prize: VU professor received the prestigious Kavli Prize

VU Siksnys

Vilnius University (VU) professor Virginijus Šikšnys was awarded the prestigious Kavli prize for his discovery of the CRISPR-Cas9, a revolutionary DNA editing tool. The prize, which includes 1 million dollars, is rewarded every two years.

The Kavli Prize in Nanoscience will be shared between prof. V. Šikšnys and two other scientists, who also work on improving the CRISPR-Cas9 technology: Emmanuelle Charpentier from Max Planck Society, and Jennifer Doudna from University of California, Berkeley.

V. Šikšnys says that the call from the president of The Norwegian Academy of Science and Letters, announcing that he will be awarded with the Kavli prize, was a surprise. However, the scientist thinks that this technology is worth the recognition it is currently receiving.

„A reward of this scale means quite a lot, we are very happy. The fact that our team achieved this is also a huge praise for the whole science community in Lithuania. However, most importantly, this technology will allow us to cure the most complicated hereditary genetic diseases, find a better solution for organ transplants, as well as create plants that are immune to cold or heat. This technology will not only cure diseases or save human lives. It will open up new opportunities in various fields of life sciences, and the possibility to actually apply it in solving real-world issues is only a matter of time”, says prof. V. Šikšnys.

Revolution in Life Sciences

The latest research on genome editing, conducted by prof. V. Šikšnys and his team (Giedrius Gasiūnas and Tautvydas Karvelis), took the science community by storm.

After the team, led by one of the most famous CRISPR-Cas9 researchers in the world, discovered how this virus functions, it became clear that this is a universal method for editing genes in various organisms.

According to prof. V. Šikšnys, CRISPR-Cas9 is a type of molecular scissors that can be used to cut defective parts of the human DNA – and it means a revolution in life sciences is about to begin. V. Šikšnys has also received the prestigious Harvard’s Warren Alpert Foundation Prize for the same discovery two years ago. It is worth mentioning, that almost fifth of the Warren Alpert Prize laureates later also received a Nobel Prize.

“CRISPR-Cas9 is a breakthrough nanotool that will considerably enhance our understanding of genetic mechanisms. This great invention confers to society enormous capabilities for positive innovations,” says Arne Brataas, head of the Kavli nanoscience prize committee.

Researchers hope that this technology will allow to cure AIDS, Down syndrome, and hereditary heart diseases. It is also likely to improve agriculture: the invention is already being used in the development of new plant species that are immune to draughts and other unfavourable conditions.

Winners picked by the science elite

The Kavli Prize is established in partnership between The Norwegian Academy of Science and Letters, The Kavli Foundation (United States), and The Norwegian Ministry of Education and Research.

The Kavli Prize recognizes scientists for pioneering advances in human understanding of existence at its biggest, smallest, and most complex scales. Presented every two years in the fields of astrophysics, nanoscience and neuroscience, each of three international prizes consists of 1 million US dollars.

Committees, whose members are recommended by six of the world’s most renowned science societies and academies, choose laureates. The Norwegian Academy of Science and Letters appoints the three prize committees after receiving recommendations from international academies and equivalent scientific organizations: The Chinese Academy of Science, The French Academy of Sciences, The Max Planck Society (Germany), The National Academy of Sciences (US), The Norwegian Academy of Science and Letters and The Royal Society (UK).

The prize committees review the nominated candidates and submit their recommendations to the board of The Norwegian Academy of Science and Letters. The President of the Academy announces the prize winners.

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.

More information Ok